TABLE 1 North America Antimicrobial Resistance Diagnostics Market, 2018 - 2021, USD Million
TABLE 2 North America Antimicrobial Resistance Diagnostics Market, 2022 - 2028, USD Million
TABLE 3 Partnerships, Collaborations and Agreements– Antimicrobial Resistance Diagnostics Market
TABLE 4 Product Launches And Product Expansions– Antimicrobial Resistance Diagnostics Market
TABLE 5 Acquisition and Mergers– Antimicrobial Resistance Diagnostics Market
TABLE 6 North America Antimicrobial Resistance Diagnostics Market by Technology, 2018 - 2021, USD Million
TABLE 7 North America Antimicrobial Resistance Diagnostics Market by Technology, 2022 - 2028, USD Million
TABLE 8 North America PCR Market by Country, 2018 - 2021, USD Million
TABLE 9 North America PCR Market by Country, 2022 - 2028, USD Million
TABLE 10 North America Immunoassay Market by Country, 2018 - 2021, USD Million
TABLE 11 North America Immunoassay Market by Country, 2022 - 2028, USD Million
TABLE 12 North America NGS Market by Country, 2018 - 2021, USD Million
TABLE 13 North America NGS Market by Country, 2022 - 2028, USD Million
TABLE 14 North America Microbiology Culture Market by Country, 2018 - 2021, USD Million
TABLE 15 North America Microbiology Culture Market by Country, 2022 - 2028, USD Million
TABLE 16 North America Mass Spectrometry Market by Country, 2018 - 2021, USD Million
TABLE 17 North America Mass Spectrometry Market by Country, 2022 - 2028, USD Million
TABLE 18 North America Rapid & Point of Care Market by Country, 2018 - 2021, USD Million
TABLE 19 North America Rapid & Point of Care Market by Country, 2022 - 2028, USD Million
TABLE 20 North America Others Market by Country, 2018 - 2021, USD Million
TABLE 21 North America Others Market by Country, 2022 - 2028, USD Million
TABLE 22 North America Antimicrobial Resistance Diagnostics Market by End-user, 2018 - 2021, USD Million
TABLE 23 North America Antimicrobial Resistance Diagnostics Market by End-user, 2022 - 2028, USD Million
TABLE 24 North America Hospitals Market by Country, 2018 - 2021, USD Million
TABLE 25 North America Hospitals Market by Country, 2022 - 2028, USD Million
TABLE 26 North America Diagnostic Laboratories Market by Country, 2018 - 2021, USD Million
TABLE 27 North America Diagnostic Laboratories Market by Country, 2022 - 2028, USD Million
TABLE 28 North America Pharmaceutical, Biotechnology Companies & Others Market by Country, 2018 - 2021, USD Million
TABLE 29 North America Pharmaceutical, Biotechnology Companies & Others Market by Country, 2022 - 2028, USD Million
TABLE 30 North America Antimicrobial Resistance Diagnostics Market by Pathogen, 2018 - 2021, USD Million
TABLE 31 North America Antimicrobial Resistance Diagnostics Market by Pathogen, 2022 - 2028, USD Million
TABLE 32 North America Methicillin Resistant Staphylococcus Aureus (MRSA) Market by Country, 2018 - 2021, USD Million
TABLE 33 North America Methicillin Resistant Staphylococcus Aureus (MRSA) Market by Country, 2022 - 2028, USD Million
TABLE 34 North America Clostridium Difficile (CD) Market by Country, 2018 - 2021, USD Million
TABLE 35 North America Clostridium Difficile (CD) Market by Country, 2022 - 2028, USD Million
TABLE 36 North America Drug Resistant Campylobacter (DRC) Market by Country, 2018 - 2021, USD Million
TABLE 37 North America Drug Resistant Campylobacter (DRC) Market by Country, 2022 - 2028, USD Million
TABLE 38 North America Drug Resistant Streptococcus Pneumoniae (DRSP) Market by Country, 2018 - 2021, USD Million
TABLE 39 North America Drug Resistant Streptococcus Pneumoniae (DRSP) Market by Country, 2022 - 2028, USD Million
TABLE 40 North America Drug Resistant Neisseria Gonorrhoeae (DRNG) Market by Country, 2018 - 2021, USD Million
TABLE 41 North America Drug Resistant Neisseria Gonorrhoeae (DRNG) Market by Country, 2022 - 2028, USD Million
TABLE 42 North America Drug Resistant Salmonella (DRNTS) Market by Country, 2018 - 2021, USD Million
TABLE 43 North America Drug Resistant Salmonella (DRNTS) Market by Country, 2022 - 2028, USD Million
TABLE 44 North America Others Market by Country, 2018 - 2021, USD Million
TABLE 45 North America Others Market by Country, 2022 - 2028, USD Million
TABLE 46 North America Antimicrobial Resistance Diagnostics Market by Country, 2018 - 2021, USD Million
TABLE 47 North America Antimicrobial Resistance Diagnostics Market by Country, 2022 - 2028, USD Million
TABLE 48 US Antimicrobial Resistance Diagnostics Market, 2018 - 2021, USD Million
TABLE 49 US Antimicrobial Resistance Diagnostics Market, 2022 - 2028, USD Million
TABLE 50 US Antimicrobial Resistance Diagnostics Market by Technology, 2018 - 2021, USD Million
TABLE 51 US Antimicrobial Resistance Diagnostics Market by Technology, 2022 - 2028, USD Million
TABLE 52 US Antimicrobial Resistance Diagnostics Market by End-user, 2018 - 2021, USD Million
TABLE 53 US Antimicrobial Resistance Diagnostics Market by End-user, 2022 - 2028, USD Million
TABLE 54 US Antimicrobial Resistance Diagnostics Market by Pathogen, 2018 - 2021, USD Million
TABLE 55 US Antimicrobial Resistance Diagnostics Market by Pathogen, 2022 - 2028, USD Million
TABLE 56 Canada Antimicrobial Resistance Diagnostics Market, 2018 - 2021, USD Million
TABLE 57 Canada Antimicrobial Resistance Diagnostics Market, 2022 - 2028, USD Million
TABLE 58 Canada Antimicrobial Resistance Diagnostics Market by Technology, 2018 - 2021, USD Million
TABLE 59 Canada Antimicrobial Resistance Diagnostics Market by Technology, 2022 - 2028, USD Million
TABLE 60 Canada Antimicrobial Resistance Diagnostics Market by End-user, 2018 - 2021, USD Million
TABLE 61 Canada Antimicrobial Resistance Diagnostics Market by End-user, 2022 - 2028, USD Million
TABLE 62 Canada Antimicrobial Resistance Diagnostics Market by Pathogen, 2018 - 2021, USD Million
TABLE 63 Canada Antimicrobial Resistance Diagnostics Market by Pathogen, 2022 - 2028, USD Million
TABLE 64 Mexico Antimicrobial Resistance Diagnostics Market, 2018 - 2021, USD Million
TABLE 65 Mexico Antimicrobial Resistance Diagnostics Market, 2022 - 2028, USD Million
TABLE 66 Mexico Antimicrobial Resistance Diagnostics Market by Technology, 2018 - 2021, USD Million
TABLE 67 Mexico Antimicrobial Resistance Diagnostics Market by Technology, 2022 - 2028, USD Million
TABLE 68 Mexico Antimicrobial Resistance Diagnostics Market by End-user, 2018 - 2021, USD Million
TABLE 69 Mexico Antimicrobial Resistance Diagnostics Market by End-user, 2022 - 2028, USD Million
TABLE 70 Mexico Antimicrobial Resistance Diagnostics Market by Pathogen, 2018 - 2021, USD Million
TABLE 71 Mexico Antimicrobial Resistance Diagnostics Market by Pathogen, 2022 - 2028, USD Million
TABLE 72 Rest of North America Antimicrobial Resistance Diagnostics Market, 2018 - 2021, USD Million
TABLE 73 Rest of North America Antimicrobial Resistance Diagnostics Market, 2022 - 2028, USD Million
TABLE 74 Rest of North America Antimicrobial Resistance Diagnostics Market by Technology, 2018 - 2021, USD Million
TABLE 75 Rest of North America Antimicrobial Resistance Diagnostics Market by Technology, 2022 - 2028, USD Million
TABLE 76 Rest of North America Antimicrobial Resistance Diagnostics Market by End-user, 2018 - 2021, USD Million
TABLE 77 Rest of North America Antimicrobial Resistance Diagnostics Market by End-user, 2022 - 2028, USD Million
TABLE 78 Rest of North America Antimicrobial Resistance Diagnostics Market by Pathogen, 2018 - 2021, USD Million
TABLE 79 Rest of North America Antimicrobial Resistance Diagnostics Market by Pathogen, 2022 - 2028, USD Million
TABLE 80 Key Information – Abbott Laboratories
TABLE 81 Key information – Becton, Dickinson and Company
TABLE 82 Key information – BioMérieux S.A.
TABLE 83 KEY INFORMATION – F. Hoffmann-La Roche Ltd.
TABLE 84 Key Information – Danaher Corporation
TABLE 85 Key information – Hologic, Inc.
TABLE 86 Key Information – Vela Diagnostics Pte. Ltd.
TABLE 87 Key Information – Molsid SAS
TABLE 88 Key Information – Visby Medical, Inc.
TABLE 89 key information – Accelerated Technology Laboratories, Inc.
List of Figures
FIG 1 Methodology for the research
FIG 2 KBV Cardinal Matrix
FIG 3 Key Leading Strategies: Percentage Distribution (2018-2022)
FIG 4 Swot analysis: Abbott laboratories
FIG 5 Recent strategies and developments: BioMérieux S.A.
FIG 6 Recent strategies and developments: F. Hoffmann-La Roche Ltd.
Unique Offerings 